天宇股份(300702.SZ)：布立西坦原料药产品获得CEP证书

Group 1 - The company Tianyu Co., Ltd. (300702.SZ) has received the Certificate of Suitability for European Pharmacopoeia (CEP) issued by the European Medicines Agency for the active pharmaceutical ingredient Brivaracetam [1] - Brivaracetam is indicated for the adjunctive treatment of partial-onset seizures, particularly in patients who have inadequate response to other antiepileptic drugs [1]